Evolent Health, Inc.EVHNYSE
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank85
3Y CAGR+3.9%
5Y CAGR+7.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+3.9%/yr
vs -3.2%/yr prior
5Y CAGR
+7.5%/yr
Recent deceleration
Acceleration
+7.0pp
Accelerating
Percentile
P85
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$301.77M+14.7%
2024$263.05M-26.5%
2023$358.11M+33.0%
2022$269.27M+22.7%
2021$219.50M+4.3%
2020$210.41M-11.0%
2019$236.45M-22.8%
2018$306.31M+48.9%
2017$205.67M+28.0%
2016$160.69M-